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Abstract
Background: Arterial stiffness increases pressure load to the left ventricle (LV), leading to LV hypertrophy and
subendocardial ischemia. Neurohormones stimulate myocardial fibrosis and LV dysfunction. We aimed to explore
the associations of arterial stiffness and plasma aldosterone with multi-directional, layer-specific LV, and left atrial
(LA) mechanical function in hypertensive patients.
Methods: Layer-specific LV global longitudinal strain (GLS-trans, GLS-endo, GLS-epi), global circumferential strain
(GCS-trans, GCS-endo, GCS-epi), LV torsional parameters, and LA global longitudinal strain (LA GLS) were analyzed
by two-dimensional speckle tracking echocardiography in 195 hypertensive patients (110 men, mean age 55 years).
Pulse wave velocity (PWV) was analyzed as a measure of arterial stiffness, and plasma aldosterone was measured for
evaluation of neurohormonal activation.
Results: In a simple correlation, PWV significantly correlated with LV GLS-endo and LA GLS. Log aldosterone correlated
with both LV GCS-endo and LV GCS-trans. Multiple regression analysis revealed that LV GLS-endo (β= 0.223, p= 0.031) and
LA GLS (β = −0.311, p = 0.002) were independently correlated with PWV even after controlling for confounding factors.
Conclusions: In hypertensive patients without clinically apparent target organ damage, LV GLS, especially endocardium,
and LA GLS were more dominantly affected by arterial stiffness because, among the three myocardial layers, the
endocardium is most susceptible to pressure overload. Two-dimensional layer-specific speckle-tracking echocardiography
sensitively detects LV mechanical dysfunction and provides pathophysiologic insights into LV mechanical adaptations
in hypertension.
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Background
Cardiac remodeling in hypertensive disease is a complex
process involving both mechanical stress from central
arterial stiffness and neurohormonal factors [1]. Arterial
stiffness increases pressure load to the LV, increasing the
size of myocytes and leading to LV hypertrophy. Neuro-
hormones also play important roles in adverse remodel-
ing of LV. Previous experimental studies revealed that
aldosterone induced myocardial fibrosis, hypertrophy,
and dysfunction [2, 3].
Progressive remodeling of LV is suggested to be het-
erogeneous across the LV wall [4]. The myocardium is
composed of three myocardial layers; during the course
of LV remodeling, central arterial stiffness and neuro-
hormones can have different degrees of impact on the
layers of the myocardium. Two-dimensional speckle
tracking echocardiography provides quantitative infor-
mation regarding LV deformation by longitudinal, cir-
cumferential, and torsion strain of myocardium [5].
Recently, layer-specific speckle-tracking echocardiog-
raphy was reported to allow quantification of LV global
longitudinal strain (GLS) and circumferential strain
(GCS) of the three layers of the myocardium [6].
The aim of this study was to explore the associations
of central arterial stiffness and plasma aldosterone with
layer-specific LV and LA mechanical function in patients
with early hypertension using two-dimensional speckle
tracking echocardiography.
Methods
Study subjects
This study was designed as a retrospective cohort study.
We included consecutive adult hypertensive patients
without apparent end organ damage who underwent
clinically indicated echocardiography between 2010 and
2015. Patients with reduced ejection fraction (< 50%),
significant valvular heart disease, ischemic heart disease,
idiopathic dilated cardiomyopathy, restrictive cardiomy-
opathy or hypertrophic cardiomyopathy, or atrial fibrilla-
tion were excluded from the study. Finally, a total of 195
patients were reviewed. Hypertension (HTN) was
defined as systolic blood pressure (SBP) ≥ 140 mmHg,
diastolic blood pressure (DBP) ≥ 90 mmHg, or current
pharmacological treatment for HTN. Clinical data at the
time of echocardiography were gathered from elec-
tronic medical records. Venous blood was collected in
the morning after a 12-h fast with the patients in the
sitting position to measure plasma aldosterone and
renin on the same day as the echocardiography. Plasma
aldosterone concentration (ng/dL) was measured by
radioimmunoassay (Diagnostic Systems Laboratories
Inc., TX). Plasma renin activity was measured by radio-
immunoassay of angiotensin I in the presence of
reagents that inhibit angiotensin I–converting enzyme
and angiotensinases. The assay was performed accord-
ing to the method of Sealey using gammacoat plasma
renin activity radioimmunoassay kits (DiaSorin [Stillwa-
ter, MN], lower limit of determination is 0.1 ng/mL/h).
Assessments of peripheral and central BPs
Peripheral SBP and DBP measurements were performed
automatically (Omron M4 Plus, Japan) at the brachial
artery of the non-dominant arm in a relaxed seated
position. Two BP measurements obtained at an interval of
5 min during the same visit were averaged. Central
hemodynamics and parameters were assessed with pulse
wave analysis of the radial artery using commercially avail-
able radial artery tonometry (SphygmoCor, AtCor Medical,
Sydney, Australia) [7, 8]. The measurements were obtained
in the supine position after a minimum of 5 min of rest just
before the echocardiogram. Peripheral pressure wave form
was recorded from the radial artery with a high-fidelity
micromanometer (Millar Instruments, Houston, TX) [8, 9].
Central systolic blood pressure (BP), diastolic BP, pulse
pressure (PP), augmentation pressure, and augmentation
index (AIx) were analyzed from 20 sequential pulse wave-
forms. PP was calculated as the difference between SBP
and DBP. Augmentation pressure was the maximum sys-
tolic pressure minus pressure at the inflection point. The
AIx was defined as AP divided by PP and expressed as a
percentage. As in previous studies, because AIx is influ-
enced by the heart rate, it was normalized for a heart rate
of 75 bpm (AIx@75) [10]. Pulse wave velocity (PWV) was
measured using carotid-femoral pressure pulse transit time.
Two-dimensional and Doppler echocardiography
Each patient underwent a comprehensive transthoracic
echocardiographic study using a Vivid 7 or Vivid 9 cardio-
vascular ultrasound system (GE Medical Systems, Horten,
Norway), equipped with 2.5–3.5 MHz phased-array sector
probes. Standard 2D and Doppler measurements were
performed according to the recommendations of the
American Society of Echocardiography guidelines [11].
LV hypertrophy was diagnosed according to the
American Society of Echocardiography recommended
formula for estimation of LV mass index and was
indexed to body surface area (cutoff values for LV mass
index were > 115 g/m2 for men and > 95 g/m2 for
women). From the apical window, mitral inflow veloci-
ties were traced, and the following variables were ob-
tained: peak velocity of early diastolic mitral inflow (E),
late diastolic mitral inflow (A), and deceleration time of
the E velocity. Early diastolic mitral annular velocity (e’),
late diastolic mitral annular velocity, and systolic mitral
annular velocity (S′) were measured from the apical four-
chamber view with a 2- to 5-mm sample volume placed at
the septal corner of the mitral annulus.
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Two-dimensional speckle tracking strain analysis
Three consecutive cardiac cycles were recorded and av-
eraged, and the frame rates were set to 60–80 frames/s.
The analysis was performed offline using customized
software (EchoPAC PC, version 113; GE Medical Sys-
tems). The endocardial border of the LV was manually
traced from three apical views (apical 4-, 2-, and 3-
chamber views) to obtain LV global longitudinal strain
of endocardial (GLS-endo), transmural (GLS-trans), and
epicardial strains (GLS-epi) by averaging all regional
peak longitudinal strains. Layer-specific LV global cir-
cumferential strain (GCS) was obtained from averaging
all circumferential strains from the short axis view of the
mitral valve, papillary muscle, and LV apex level (LV
GCS-endo, LV GCS-trans, LV GCS-epi). LV Torsion
was automatically calculated as the instantaneous differ-
ence between LV apical and LV basal rotation.
The global longitudinal strain of the LA (LA-GLS) was
measured by manually tracing the LA endocardial
border in both four-chamber and two-chamber views.
Because two segments of the LA roof demonstrated
lower longitudinal strain curves than the other four, they
were excluded from both 4-chamber and 2-chamber
views. Therefore, global peak LALS during ventricular
systole was measured by averaging the values obtained
in the eight other LA segments. The time to peak LALS
was also measured as the average of the eight segments
and by calculating the time delay from the QRS to the
positive peak LALS [12].
To examine intraobserver and interobserver variability
for layer-specific LV GLS and GCS, the same observer
and a second independent observer repeated the analysis
of the first 10 consecutive patients. Intraobserver and in-
terobserver intraclass coefficients were as follows: 0.97
(95% confidence interval [CI] 0.96–0.98) and 0.96 (95% CI
0.96–0.98) for LV GLS-endo; 0.96 (95% CI 0.93–0.98) and
0.95 (95% CI 0.90–0.99) for LV GLS-trans; 0.93 (95% CI
0.78–0.96) and 0.89 (95% CI 0.64–0.95) for LV GLS epi;
0.93 (95% CI 0.90–0.98) and 0.95 (95% CI 0.92–0.98) for
LV GCS-endo; 0.96 (95% CI 0.93–0.98) and 0.94 (95% CI
0.89–0.98) for LV GCS-trans; 0.91 (95% CI 0.75–0.96) and
0.88 (95% CI 0.62–0.95) for LV GCS epi; 0.88 (95% CI
0.84–0.92) and 0.90 (95% CI 0.85–0.95) for LA GLS.
Statistical analysis
Continuous variables are presented as mean ± SD and
categorical variables are presented as absolute and rela-
tive frequencies (%). Spearman’s simple correlation ana-
lyses were performed to determine the associations
between strain parameters and parameters of arterial
stiffness and log aldosterone. Multiple linear regressions
were performed to determine the independent associ-
ation of LV mechanical parameters with arterial stiffness
and neurohormone.
Results
Demographic characteristics
Table 1 shows baseline characteristics of our cohort.
Mean age was 55 ± 13, and 96 patients (49%) were men.
Regarding medication, 108 (55%) patients were taking
angiotensin-converting enzyme inhibitors or angiotensin
receptor blockers at the time of echocardiography. LV
hypertrophy was present in 52 (27%) patients. Table 2
shows echocardiographic findings in our cohort. Mean
left atrial volume index (24.5 ml/m2 ± 7.9) and E/E’ value
(10.4 ± 3.5) were in the normal range. The mean value of
LV GLS-trans was −16.9 ± 2.9, which was slightly lower
than the normal value [11].
Central hemodynamics and neurohormone and the
indices of LV mechanical function
Table 3 shows simple correlation analysis between strain
parameters and PWV or log aldosterone. In a simple
correlation, PWV was well correlated with LV GLS-endo
(r = 0.169, p = 0.046) and LA GLS (r = −0.250, p = 0.003).
Table 1 Baseline characteristics of the study population
n = 195
Demographics
Age, years 55 ± 13
Male gender, n (%) 96 (49)
Body mass index, kg/m2 24.8 ± 3.7
Dyslipidemia, n (%) 50 (26)
Smoking, n (%) 21 (11)
Medications
RAAS blockers, n (%) 108 (55)
Beta blockers, n (%) 39 (20)
Calcium channel blockers, n (%) 68 (35)
Diuretics, n (%) 19 (10)
Hemodynamics
Peripheral SBP, mmHg 148 ± 76
Peripheral DBP, mmHg 83 ± 13
Peripheral PP, mmHg 61 ± 15
Central SBP, mmHg 132 ± 18
Central DBP, mmHg 85 ± 13
Central PP, mmHg 48 ± 14
AIx@75, % 24 ± 12
Heart rate, bpm 68 ± 12
PP amplification 1.31 ± 0.21
PWV, m/s 8.3 ± 1.8
Aldosterone, ng/dL 16.03 (12.15–19.53)
Renin, ng/mL/h 1.55 (0.68–3.71)
RAAS renin angiotensin aldosterone system, SBP systolic blood pressure,
DBP diastolic blood pressure, PP pulse pressure, AIx augmentation index,
PWV pulse wave velocity
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PWV showed significant correlation with LV GLS-endo
even in patients without LV hypertrophy(Fig. 1). Other
central hemodynamic parameters, such as PP amplifica-
tion or AIx@ 75, did not show significant correlation
with strain parameters. Log aldosterone showed posi-
tive correlation with LV GCS-endo (r = 0.251, p = 0.019)
and LV GCS-trans (r = 0.240, p = 0.024), whereas no
significant correlation was observed with LV GLS of
any layer. Unlike the correlation between LV GLS-endo
and PWV, log aldosterone did not show a significant
correlation with LV GCS-endo in patients without LV
hypertrophy (Fig. 2).
Multiple regression analysis revealed that LV GLS-
endo (beta = 0.223, p = 0.031) and LA GLS (beta = −0.318,
p = 0.002) were independently correlated with PWV, even
after controlling for confounding factors such as age,
gender, body mass index, presence of diabetes
mellitus, LV mass index, LV ejection fraction, and use
of renin aldosterone angiotensin (RAAS) blockers
(Table 4).
Discussion
This study presents correlation of LA and LA mechan-
ical function with increased arterial stiffness and neuro-
hormone level in patients with early hypertension
without clinically apparent target organ damage. The
principle finding from our results is that LV GLS, espe-
cially endocardium, and LA GLS were dominantly af-
fected by central arterial stiffness in early hypertensive
patients without clinically apparent target organ damage.
Two-dimensional speckling analysis provides sensitive
assessment of mechanical function of LV and LA.
Recently, LV GLS gained clinical significance in patients
with hypertensive heart disease. Lee et al. showed that
LV GLS, especially that of the epicardial layer, was the
only independent predictor of events [13]. Saito et al.
showed that LV GLS had additive predictive value to
clinical risk factors and concentric LV hypertrophy for
predicting adverse cardiovascular outcomes in asymp-
tomatic hypertensive patients [14]. The mechanism for
impaired longitudinal strain in hypertension has been
studied recently. In an animal study, when LV GLS was
compared with transmural histology of myocardium,
fibrosis was predominant in the subendocardial layer,
and longitudinal deformation of the LV was affected
mainly by subendocardial fibrosis, whereas circumferen-
tial and radial strain were preserved until the late phase
of the experiment [15]. Investigators demonstrated
propagation of fibrosis from the subendocardium to the
mid layer of the myocardium as HTN persisted, which
affected radial strain in the late course. This finding is
consistent with our data. From our data, PWV correlated
Table 2 Two-dimensional, Doppler, and speckle tracking
echocardiography
n = 195
Two-dimensional and Doppler
LV end-diastolic dimension, mm 48 ± 5
LV end-systolic dimension, mm 31 ± 4
IVS thickness, mm 9.6 ± 1.9
PW thickness, mm 9.4 ± 1.4
Relative wall thickness 0.41 ± 0.25
LV mass index, g/m2 92 ± 25
LV hypertrophy, n (%) 52 (27)
LV ejection fraction, % 67.9 ± 5.8
e’ velocity, cm/s 6.8 ± 2.5
S′ velocity, cm/s 7.4 ± 1.5
E/e’ 10.4 ± 3.5
LA volume index, ml/m2 24.7 ± 7 .9
Two-dimensional speckle tracking
LV GLS, %
Transmural −16.9 ± 2.9
Endocardial −19.1 ± 3.3
Epicardial −14.9 ± 2.8
LV GRS, % 34.1 ± 12.2
LV GCS, %
Transmural −22.0 ± 5.0
Endocardial - 34.3 ± 6.9
Epicardial −15.4 ± 5.7
LV Torsion, peak (°) 27.2 ± 9.5
LA GLS, % 31.7 ± 9.1
LV left ventricle, IVS interventricular septum, PW posterior wall, LA left atrium,
GLS global longitudinal strain, GRS global radial strain,
GCS global circumferential strain, SD standard deviation
Table 3 Simple correlations
PWV Log Aldosterone
R P-value R P-value
LV GLS
Transmural 0.145 0.090 0.062 0.511
Endocardial 0.169 0.046 0.052 0.586
Epicardial 0.162 0.056 0.056 0.552
LV GRS 0.036 0.710 −0.168 0.123
LV GCS
Transmural −0.039 0.689 0.240 0.024
Endocardial 0.016 0.870 0.251 0.019
Epicardial −0.021 0.832 0.078 0.477
LV Torsion, peak 0.026 0.786 −0.139 0.191
LA GLS −0.250 0.003 0.018 0.854
LV left ventricle, LA left atrium, GLS global longitudinal strain, GRS global radial
strain, GCS global circumferential strain
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well with LV GLS-endo. The significance of the correl-
ation between PWV and LV GLS-endo was significant
even in patients without LV hypertrophy.
In addition, LA GLS showed independent correlation
with PWV. Although current guidelines recommend as-
sessment for presence of LV hypertrophy as a sign of
target organ damage, increased LA size is strongly asso-
ciated with the duration and level of systolic blood pres-
sure [16]. Change of LA mechanical function and
enlargement of LA can occur even before LV hyper-
trophy [17]. It is interesting that our data showed a
significant correlation between LA GLS and PWV when
most of patients did not have an enlarged LA, reflecting
changes in mechanical function before structural adapta-
tion. A previous study with a small number of patients
showed reverse remodeling of LA with treatment of
quinapril and independent correlation with improved
central arterial stiffness [18]. Our finding suggests that
LA GLS can serve as a sensitive surrogate marker for
treatment response or risk stratification in early hyper-
tensive patients who do not have enlarged LA or LV
hypertrophy.
The renin-aldosterone system is reported to cause
subendocardial fibrosis and stimulate hypertrophy of
myocytes [19, 20]. In our study, log aldosterone
showed significant correlation with LV GCS-endo and
LV GCS-trans from simple correlation analysis,
whereas no significant correlation was observed
between LV GLS and log aldosterone. The correlation
between LV GCS and log aldosterone was not signifi-
cant in patients without LV hypertrophy. Although this
finding cannot be fully explained due to the cross-
sectional nature of our study, the data suggest that
neurohormonal factors affect myocardium in a differ-
ent manner from mechanical stress due to increased
arterial stiffness. A previous animal study suggested
that circumferential strain is affected by later stages of
HTN, as progressive fibrosis affects the middle layer of
the myocardium. In our study, the correlation between
LV GCS-endo and log aldosterone failed to show
significance in multivariate analysis. This might reflect
the characteristics of our study cohort. Many of the
patients in our study were in early stages of hyperten-
sion, and 61 (31%) had undetectable plasma aldosterone
Fig. 2 Correlation between strain parameters and log aldosterone
Fig. 1 Correlation between strain parameters and PWV
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and renin. The correlation between neurohormone and
LV mechanics should be studied in a large number of pa-
tients with more advanced hypertension.
Early detection of cardiac structural changes in early
hypertension is important with regard to risk stratifica-
tion. Based on the findings from our study, LV and LA
remodeling in early hypertension can be hypothesized as
outlined in Fig. 3. Mechanical stress from pressure over-
load impairs LV GLS of the endocardium and LA GLS.
Neurohormones and aldosterone can impair LV GCS of
the endocardium and transmural myocardium as hyper-
tension progresses.
Limitations
Several limitations of this study need to be noted. First,
we included patients with early hypertension. Patients
with LV hypertrophy represented only 27% of our
cohort, and the small number of patients with LV hyper-
trophy might have affected the correlation analysis of
the LV hypertrophy subgroup. Second, 51% of our
patients were on RAAS blockers, which might have
affected reverse remodeling of LV. However, we included
use of RAAS blocker in multivariate analysis to
minimize confounding effects. Third, because of the
cross-sectional design of our study, we could not deter-
mine whether treatment of HTN can reverse abnormal
LV mechanics. All of these issues are relevant and
should be examined in future studies.
Conclusion
Central arterial stiffness was independently correlated
with LV GLS, especially endocardium, because the
endocardium is the most susceptible to pressure over-
load among the three myocardial layers. Also, central
arterial stiffness showed an independent negative
correlation with LA GLS. Aldosterone showed signifi-
cant positive correlation with LV GCS, especially endo-
cardium from simple correlation, however, failed to
remain significant in multivariate analysis. Different
Table 4 Determinants for myocardial mechanical function
β t p-value
LV GLS endocardium (R2 = 0.327)
Age −0.170 −1.48 0.142
Female gender −0.112 −1.22 0.225
Body mass index 0.046 0.49 0.626
Diabetes mellitus 0.062 0.66 0.511
Peripheral SBP 0.024 0.26 0.795
LV ejection fraction −0.419 −4.44 <0.001
LV mass index −0.001 −0.01 0.995
Use of RAAS blocker 0.158 1.76 0.082
PWV 0.223 2.19 0.031
LV GCS endocardium (R2 = 0.164)
Age 0.190 1.21 0.231
Female gender −0.130 −1.06 0.294
Body mass index 0.076 0.63 0.534
Diabetes mellitus 0.108 0.87 0.385
Peripheral SBP 0.004 0.04 0.970
LV ejection fraction −0.293 −2.35 0.022
LV mass index −0.015 −0.13 0.896
Use of RAAS blocker −0.091 −0.76 0.448
Log Aldosterone 0.201 1.61 0.112
LA GLS (R2 = 0.361)
Age −0.118 −1.05 0.297
Female gender −0.096 −1.06 0.292
Body mass index −0.179 −1.94 0.055
Diabetes mellitus −0.158 −1.70 0.092
Peripheral SBP −0.044 −0.50 0.622
LV ejection fraction 0.218 2.35 0.021
LV mass index −0.065 −0.74 0.461
Use of RAAS blocker −0.318 −3.59 0.001
PWV −0.311 −3.12 0.002
SBP systolic blood pressure, LV left ventricle, RAAS renin angiotensin
aldosterone system, PWV pulse wave velocity
Fig. 3 Hypothesis on LV and LA remodeling in early hypertension
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correlations between strain parameters and central ar-
terial stiffness or aldosterone suggest different func-
tional adaptations of LV and LA to arterial stiffness and
neurohormone. In addition, two-dimensional layer-
specific speckle-tracking echocardiography sensitively
detected LV and LA mechanical adaptation in early
hypertension, even without LV hypertrophy, and pro-
vided pathophysiologic insights into LV and LA remod-
eling in association with central stiffness.
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